Meanwhile, based on the functional enrichment and pathway analysis of ACACB, we found that many classic pathways in CRC tumorigenesis (such as EGFR tyrosine kinase inhibitor resistance, focal adhesion, and the mTOR signaling pathway) may be downstream pathways of ACACB in CRC. This evidence concerns the gene EGFR and colorectal carcinoma.